首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Relationship of Plasma N‐terminal Pro‐brain Natriuretic Peptide Concentrations to Heart Failure Classification and Cause of Respiratory Distress in Dogs Using a 2nd Generation ELISA Assay
Authors:PR Fox  MA Oyama  MJ Hezzell  JE Rush  TP Nguyenba  TC DeFrancesco  LB Lehmkuhl  HB Kellihan  B Bulmer  SG Gordon  SM Cunningham  J MacGregor  RL Stepien  B Lefbom  D Adin  K Lamb
Institution:1. The Animal Medical Center, New York, NY;2. University of Pennsylvania, Philadelphia, PA;3. Tufts University Cummings School of Veterinary Medicine, North Grafton, MA;4. MedVet Medical & Cancer Center for Pets, Worthington, OH;5. North Carolina State University, Raleigh, NC;6. University Wisconsin, Madison, WI;7. Oregon State College of Veterinary Medicine, Corvalis, OR;8. Texas A&M University, College Station, TX;9. InTown Veterinary Group, Woburn, MA;10. Chesapeake Veterinary Cardiology Associates, Springfield, VA;11. Lamb Statistical Consulting, West St. Paul, MN
Abstract:

Background

Cardiac biomarkers provide objective data that augments clinical assessment of heart disease (HD).

Hypothesis/Objectives

Determine the utility of plasma N‐terminal pro‐brain natriuretic peptide concentration NT‐proBNP] measured by a 2nd generation canine ELISA assay to discriminate cardiac from noncardiac respiratory distress and evaluate HD severity.

Animals

Client‐owned dogs (n = 291).

Methods

Multicenter, cross‐sectional, prospective investigation. Medical history, physical examination, echocardiography, and thoracic radiography classified 113 asymptomatic dogs (group 1, n = 39 without HD; group 2, n = 74 with HD), and 178 with respiratory distress (group 3, n = 104 respiratory disease, either with or without concurrent HD; group 4, n = 74 with congestive heart failure CHF]). HD severity was graded using International Small Animal Cardiac Health Council (ISACHC) and ACVIM Consensus (ACVIMHD) schemes without knowledge of NT‐proBNP] results. Receiver‐operating characteristic curve analysis assessed the capacity of NT‐proBNP] to discriminate between dogs with cardiac and noncardiac respiratory distress. Multivariate general linear models containing key clinical variables tested associations between NT‐proBNP] and HD severity.

Results

Plasma NT‐proBNP] (median; IQR) was higher in CHF dogs (5,110; 2,769–8,466 pmol/L) compared to those with noncardiac respiratory distress (1,287; 672–2,704 pmol/L; < .0001). A cut‐off >2,447 pmol/L discriminated CHF from noncardiac respiratory distress (81.1% sensitivity; 73.1% specificity; area under curve, 0.84). A multivariate model comprising left atrial to aortic ratio, heart rate, left ventricular diameter, end‐systole, and ACVIMHD scheme most accurately associated average plasma NT‐proBNP] with HD severity.

Conclusions and Clinical Importance

Plasma NT‐proBNP] was useful for discriminating CHF from noncardiac respiratory distress. Average plasma NT‐BNP] increased significantly as a function of HD severity using the ACVIMHD classification scheme.
Keywords:Biomarkers  Canine  Heart disease  Respiratory distress
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号